PD
Pearl Diagnostics, Inc.
SEC filingBiotechnology · Baltimore, MD
Amount raised$11.2Msold at filing
Total offering$11.2M
Investors in the raise21count reported to the SEC
FiledApr 21, 2026first sale Mar 19, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Brad SpellbergDirector
Eric GornsteinExecutive Officer, Director
John CammackDirector
Kieren MarrExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.